jack and jill semaglutide Injectable | Compounded GLP-1 We got you covered for

It is an investigational compound most appropriate for patients who have tried and plateaued on approved GLP-1 therapies, or who have specific metabolic presentations where triple agonism is clinically justified

With this approval, and by launching a generic for Saxenda, we will provide patients in the US the first ever generic GLP-1 product specifically indicated for weight loss, said Ernie Richardsen, senior vice president, Head of US Commercial Generics at Teva

This is especially relevant for patients also taking insulin or sulfonylureas, who should monitor for hypoglycemia symptoms

All products are intended for laboratory research purposes only and are not for human consumption or medical use

This combined approach boosts its effectiveness, helping more patients reach ambitious weight loss milestones